TNDM
Income statement / Annual
Last year (2025), Tandem Diabetes Care Inc's total revenue was $1.01 B,
an increase of 7.93% from the previous year.
In 2025, Tandem Diabetes Care Inc's net income was -$204.71 M.
See Tandem Diabetes Care Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.01 B |
$940.20 M |
$747.72 M |
$801.22 M |
$702.80 M |
$498.83 M |
$362.31 M |
$183.87 M |
$107.60 M |
$84.25 M |
| Cost of Revenue |
$483.89 M
|
$450.63 M
|
$380.03 M
|
$388.23 M
|
$326.58 M
|
$238.31 M
|
$168.09 M
|
$94.04 M
|
$63.51 M
|
$60.66 M
|
| Gross Profit |
$530.85 M
|
$489.57 M
|
$367.69 M
|
$412.99 M
|
$376.22 M
|
$260.52 M
|
$194.21 M
|
$89.82 M
|
$44.09 M
|
$23.59 M
|
| Gross Profit Ratio |
0.52
|
0.52
|
0.49
|
0.52
|
0.54
|
0.52
|
0.54
|
0.49
|
0.41
|
0.28
|
| Research and Development Expenses |
$174.84 M
|
$198.88 M
|
$248.42 M
|
$170.15 M
|
$92.05 M
|
$63.57 M
|
$45.20 M
|
$29.23 M
|
$20.66 M
|
$18.81 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$86.38 M
|
$82.83 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$434.13 M
|
$389.82 M
|
$352.50 M
|
$335.68 M
|
$261.51 M
|
$204.90 M
|
$165.74 M
|
$105.23 M
|
$86.38 M
|
$82.83 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$608.97 M
|
$588.70 M
|
$600.92 M
|
$505.83 M
|
$353.56 M
|
$268.48 M
|
$210.93 M
|
$134.45 M
|
$107.04 M
|
$101.64 M
|
| Cost And Expenses |
$1.09 B
|
$1.04 B
|
$980.95 M
|
$894.07 M
|
$680.15 M
|
$506.79 M
|
$379.03 M
|
$228.50 M
|
$170.55 M
|
$162.30 M
|
| Interest Income |
$9.09 M
|
$17.99 M
|
$22.86 M
|
$6.06 M
|
$674.00 K
|
$1.57 M
|
$3.27 M
|
$1.46 M
|
$239.00 K
|
$296.00 K
|
| Interest Expense |
$7.91 M
|
$7.42 M
|
$9.88 M
|
$6.21 M
|
$6.04 M
|
$12.81 M
|
$78.00 K
|
$7.58 M
|
$11.34 M
|
$5.71 M
|
| Depreciation & Amortization |
$17.67 M
|
$158.00 K
|
$15.72 M
|
$14.33 M
|
$13.85 M
|
$10.45 M
|
$6.07 M
|
$5.82 M
|
$6.87 M
|
$5.49 M
|
| EBITDA |
-$174.70 M |
-$99.13 M |
-$196.46 M |
-$74.21 M |
$34.06 M |
-$13.03 M |
-$18.45 M |
-$109.16 M |
-$54.82 M |
-$72.27 M |
| EBITDA Ratio |
-0.17
|
-0.11
|
-0.26
|
-0.09
|
0.05
|
-0.03
|
-0.05
|
-0.59
|
-0.51
|
-0.86
|
| Operating Income Ratio |
-0.08
|
-0.11
|
-0.31
|
-0.12
|
0.03
|
-0.02
|
-0.05
|
-0.24
|
-0.58
|
-0.93
|
| Total Other Income/Expenses Net |
-$122.15 M
|
$7.26 M
|
$12.98 M
|
-$4.00 K
|
-$6.75 M
|
-$28.33 M
|
-$7.88 M
|
-$77.93 M
|
-$10.08 M
|
-$5.41 M
|
| Income Before Tax |
-$200.27 M
|
-$91.87 M
|
-$220.25 M
|
-$92.85 M
|
$15.90 M
|
-$36.28 M
|
-$24.60 M
|
-$122.56 M
|
-$73.03 M
|
-$83.46 M
|
| Income Before Tax Ratio |
-0.2
|
-0.1
|
-0.29
|
-0.12
|
0.02
|
-0.07
|
-0.07
|
-0.67
|
-0.68
|
-0.99
|
| Income Tax Expense |
$4.44 M
|
$4.16 M
|
$2.36 M
|
$1.74 M
|
$335.00 K
|
-$1.90 M
|
$149.00 K
|
$51.00 K
|
$8.00 K
|
-$15.00 K
|
| Net Income |
-$204.71 M
|
-$96.03 M
|
-$222.61 M
|
-$94.59 M
|
$15.57 M
|
-$34.38 M
|
-$24.75 M
|
-$122.61 M
|
-$73.03 M
|
-$83.45 M
|
| Net Income Ratio |
-0.2
|
-0.1
|
-0.3
|
-0.12
|
0.02
|
-0.07
|
-0.07
|
-0.67
|
-0.68
|
-0.99
|
| EPS |
-3.04 |
-1.47 |
-3.43 |
-1.47 |
0.25 |
-0.56 |
-0.42 |
-2.55 |
-12.86 |
-27.3 |
| EPS Diluted |
-3.04 |
-1.47 |
-3.43 |
-1.47 |
0.24 |
-0.56 |
-0.42 |
-2.55 |
-12.86 |
-27.3 |
| Weighted Average Shares Out |
$67.29 M
|
$65.45 M
|
$64.90 M
|
$64.15 M
|
$63.00 M
|
$60.99 M
|
$58.51 M
|
$48.13 M
|
$5.68 M
|
$3.06 M
|
| Weighted Average Shares Out Diluted |
$67.29 M
|
$65.45 M
|
$64.97 M
|
$64.15 M
|
$64.35 M
|
$60.99 M
|
$58.51 M
|
$48.13 M
|
$5.68 M
|
$3.06 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
